Sphera Funds Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Sphera Funds Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-88,015	Closed	-$4.53M	–	127
2019 Q1	$4.53M	Sell	88,015 -45,000	-34%	-$1.94M	0.41%	57
2018 Q4	$4.92M	Sell	133,015 -22,500	-14%	-$811K	0.55%	42
2018 Q3	$5.84M	Buy	155,515 +18,127	+13%	+$667K	0.67%	38
2018 Q2	$5.43M	Buy	137,388 +6,288	+5%	+$200K	0.75%	36
2018 Q1	$3.38M	Buy	+131,100	New	+$3.92M	0.51%	55

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sphera Funds Management's BHVN Position: Q2 2019 in Review

Sphera Funds Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2019, closing a stake of 88,015 shares — an estimated $4.53M sold.

Sphera Funds Management first reported a position in BHVN in Q1 2018 and held it in 5 quarters. The position peaked at $5.84M in Q3 2018. 197 funds tracked by Wall St. Rank hold BHVN as of Q2 2019.

Sphera Funds Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2019 after selling out during the quarter.
Sphera Funds Management sold 88,015 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2019, an estimated $4.53M.
Sphera Funds Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 5 quarters.
Sphera Funds Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $5.84M in Q3 2018.
197 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.